Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.77
-0.54 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
38.51
-0.26 (-0.67%)
After-hours: Dec 5, 2025, 7:58 PM EST
Cogent Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 125.3 | 98.17 | 53.23 | 139.89 | 219.68 | 242.19 | Upgrade
|
| Short-Term Investments | 265.59 | 188.91 | 212.48 | 119.39 | - | - | Upgrade
|
| Cash & Short-Term Investments | 390.89 | 287.08 | 265.71 | 259.28 | 219.68 | 242.19 | Upgrade
|
| Cash Growth | 16.50% | 8.04% | 2.48% | 18.02% | -9.29% | 547.15% | Upgrade
|
| Prepaid Expenses | 6.35 | 9.4 | 5.06 | 4.44 | 2.95 | 2.72 | Upgrade
|
| Restricted Cash | - | - | - | 1.26 | - | - | Upgrade
|
| Total Current Assets | 397.24 | 296.47 | 270.77 | 264.97 | 222.63 | 244.91 | Upgrade
|
| Property, Plant & Equipment | 23.87 | 26.56 | 30.34 | 31.1 | 4.48 | 4.75 | Upgrade
|
| Long-Term Investments | - | - | 7.46 | - | - | - | Upgrade
|
| Other Long-Term Assets | 4.82 | 4.86 | 4.86 | 4.75 | 4.98 | 1.26 | Upgrade
|
| Total Assets | 425.93 | 327.9 | 313.44 | 300.81 | 232.09 | 250.92 | Upgrade
|
| Accounts Payable | 16.03 | 12.01 | 10.66 | 5.84 | 3.48 | 0.73 | Upgrade
|
| Accrued Expenses | 43.23 | 41.76 | 25.69 | 17.48 | 7.98 | 4.47 | Upgrade
|
| Current Portion of Leases | 1.71 | 1.57 | 1.39 | 1.42 | 2.32 | 2.05 | Upgrade
|
| Other Current Liabilities | 1.29 | 0.37 | 0.44 | 2.1 | 3.3 | 5.84 | Upgrade
|
| Total Current Liabilities | 62.25 | 55.71 | 38.17 | 26.85 | 17.08 | 13.09 | Upgrade
|
| Long-Term Leases | 14.6 | 15.9 | 17.47 | 18.23 | 0.83 | 3.16 | Upgrade
|
| Other Long-Term Liabilities | 2.37 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 123.47 | 71.61 | 55.64 | 45.08 | 17.91 | 16.25 | Upgrade
|
| Common Stock | 0.14 | 0.11 | 0.09 | 0.07 | 0.04 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 1,280 | 1,005 | 801.06 | 601.15 | 399.71 | 322.45 | Upgrade
|
| Retained Earnings | -1,086 | -859.48 | -603.62 | -411.21 | -270.97 | -198.7 | Upgrade
|
| Comprehensive Income & Other | 0.21 | 0.45 | 0.25 | -0.1 | - | - | Upgrade
|
| Total Common Equity | 194.55 | 145.69 | 197.77 | 189.91 | 128.78 | 123.79 | Upgrade
|
| Shareholders' Equity | 302.46 | 256.29 | 257.8 | 255.74 | 214.18 | 234.67 | Upgrade
|
| Total Liabilities & Equity | 425.93 | 327.9 | 313.44 | 300.81 | 232.09 | 250.92 | Upgrade
|
| Total Debt | 60.56 | 17.47 | 18.85 | 19.65 | 3.16 | 5.21 | Upgrade
|
| Net Cash (Debt) | 330.33 | 269.61 | 254.32 | 239.63 | 216.53 | 236.98 | Upgrade
|
| Net Cash Growth | 0.80% | 6.01% | 6.13% | 10.67% | -8.63% | 654.91% | Upgrade
|
| Net Cash Per Share | 2.77 | 2.59 | 3.19 | 4.07 | 5.59 | 21.39 | Upgrade
|
| Filing Date Shares Outstanding | 142.45 | 110.54 | 103.91 | 69.95 | 45.81 | 37.19 | Upgrade
|
| Total Common Shares Outstanding | 139.9 | 110.54 | 86.12 | 69.89 | 43.81 | 32.35 | Upgrade
|
| Working Capital | 335 | 240.76 | 232.6 | 238.12 | 205.56 | 231.82 | Upgrade
|
| Book Value Per Share | 1.39 | 1.32 | 2.30 | 2.72 | 2.94 | 3.83 | Upgrade
|
| Tangible Book Value | 194.55 | 145.69 | 197.77 | 189.91 | 128.78 | 123.79 | Upgrade
|
| Tangible Book Value Per Share | 1.39 | 1.32 | 2.30 | 2.72 | 2.94 | 3.83 | Upgrade
|
| Machinery | - | 10.08 | 9.54 | 6.93 | 1.21 | 0.14 | Upgrade
|
| Construction In Progress | - | 0.04 | 0.03 | 0.48 | 0.65 | - | Upgrade
|
| Leasehold Improvements | - | 2.46 | 2.44 | 1.78 | 0.41 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.